Search Results - "de Assis, Rafael R."

Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray by de Assis, Rafael R., Jain, Aarti, Nakajima, Rie, Jasinskas, Algis, Felgner, Jiin, Obiero, Joshua M., Norris, Philip J., Stone, Mars, Simmons, Graham, Bagri, Anil, Irsch, Johannes, Schreiber, Martin, Buser, Andreas, Holbro, Andreas, Battegay, Manuel, Hosimer, Philip, Noesen, Charles, Adenaiye, Oluwasanmi, Tai, Sheldon, Hong, Filbert, Milton, Donald K., Davies, D. Huw, Contestable, Paul, Corash, Laurence M., Busch, Michael P., Felgner, Philip L., Khan, Saahir

“…The current practice for diagnosis of COVID-19, based on SARS-CoV-2 PCR testing of pharyngeal or respiratory specimens in a symptomatic patient at high…”
Get full text

Risk factors for SARS-CoV-2 seropositivity in a health care worker population during the early pandemic by Schubl, Sebastian D, Figueroa, Cesar, Palma, Anton M, de Assis, Rafael R, Jain, Aarti, Nakajima, Rie, Jasinskas, Algimantas, Brabender, Danielle, Hosseinian, Sina, Naaseh, Ariana, Hernandez Dominguez, Oscar, Runge, Ava, Skochko, Shannon, Chinn, Justine, Kelsey, Adam J, Lai, Kieu T, Zhao, Weian, Horvath, Peter, Tifrea, Delia, Grigorian, Areg, Gonzales, Abran, Adelsohn, Suzanne, Zaldivar, Frank, Edwards, Robert, Amin, Alpesh N, Stamos, Michael J, Barie, Philip S, Felgner, Philip L, Khan, Saahir

“…While others have reported severe acute respiratory syndrome-related coronavirus 2(SARS-CoV-2) seroprevalence studies in health care workers (HCWs), we…”
Get full text

Characterization of antibodies to SARS‐CoV ‐2 in lyophilized plasma prepared with amotosalen‐ UVA pathogen reduction by Martinaud, Christophe, Bagri, Anil, Tsai, Cheng‐Ting, de Assis, Rafael R., Gatmaitan, Michelle, Robinson, Peter V., Seftel, David, Khan, Saahir, Felgner, Philip L., Corash, Laurence M.

“…BackgroundSevere acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)‐infected patients exhibit disease ranging from asymptomatic to severe pneumonia,…”
Get full text

Characterization of pathogen‐inactivated COVID‐19 convalescent plasma and responses in transfused patients by Weisser, Maja, Khanna, Nina, Hedstueck, Anemone, Sutter, Sarah Tschudin, Roesch, Sandra, Stehle, Gregor, Sava, Mihaela, Deigendesch, Nikolaus, Battegay, Manuel, Infanti, Laura, Holbro, Andreas, Bassetti, Stefano, Pargger, Hans, Hirsch, Hans H., Leuzinger, Karoline, Kaiser, Laurent, Vu, Diem‐Lan, Baur, Katharina, Massaro, Nadine, Busch, Michael Paul, Simmons, Graham, Stone, Mars, Felgner, Philip L., Assis, Rafael R., Khan, Saahir, Tsai, Cheng‐ting, Robinson, Peter V., Seftel, David, Irsch, Johannes, Bagri, Anil, Buser, Andreas S., Corash, Laurence

“…Background Efficacy of donated COVID‐19 convalescent plasma (dCCP) is uncertain and may depend on antibody titers, neutralizing capacity, timing of…”
Get full text

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment by Bagri, Anil, Assis, Rafael R., Tsai, Cheng‐Ting, Simmons, Graham, Mei, Zhen W., Von Goetz, Melissa, Gatmaitan, Michelle, Stone, Mars, Di Germanio, Clara, Martinelli, Rachel, Darst, Orsolya, Rioveros, Jowin, Robinson, Peter V., Ward, Dawn, Ziman, Alyssa, Seftel, David, Khan, Saahir, Busch, Michael P., Felgner, Philip L., Corash, Laurence M.

“…Background COVID‐19 convalescent plasma (CCP), from donors recovered from severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection, is one of the…”
Get full text